The Cholesterol Myth: Unveiling the Truth About Heart Health

The Cholesterol Misconception

For generations, we've been told that cholesterol causes heart disease. This oversimplification may be one of the most harmful in modern medicine. As a result, millions of people worldwide take statin drugs, which primarily work by reducing energy production in mitochondria, essentially stealing energy from cells. The organs most affected are those that use the most energy: the brain, heart, liver, and kidneys.

One of the biggest problems with statins, or any medication, is the misconception that they solve the problem. In reality, they don't fix anything or restore balance - they merely suppress symptoms by inhibiting a bodily process. This masks the true root causes and allows underlying imbalances to worsen.

Understanding Cholesterol's Role

Cholesterol isn't the enemy or a toxin - it's an essential substance your body needs and produces. Here's a quick list of some of cholesterol's vital functions:

• Precursor for steroid hormones like testosterone, estrogen, and cortisol
• Building block for vitamin D
• Essential component of cell membranes
• Crucial for myelin sheaths in the nervous system
• Key ingredient in bile acids for fat digestion

Cholesterol is so important that your body manufactures the majority it uses. It's a natural, necessary substance that shouldn't be vilified.

The Changing Definition of "Normal" Cholesterol

Before the 1980s, total cholesterol under 300 mg/dL was considered normal. There wasn't even a cutoff point - levels had to exceed 300 before anyone considered it elevated or problematic.

However, in 1987, the first statin drug was approved, and the National Cholesterol Education Program (NCEP) was launched. Suddenly, "normal" cholesterol dropped from 300 to 200 mg/dL overnight. Anything between 200-239 mg/dL became "borderline high," and over 240 mg/dL was deemed "high."

This shift created millions of potential customers for statin drugs virtually overnight. As guidelines continued to evolve, the focus shifted to LDL cholesterol specifically:

• 1993 NCEP guidelines: LDL under 130 mg/dL desirable, 130-159 mg/dL borderline high, over 160 mg/dL high
• 2001 NCEP guidelines: Optimal LDL under 100 mg/dL, near optimal 100-129 mg/dL
• Later updates: High-risk individuals should aim for LDL under 70 mg/dL

With each iteration, the goalposts moved, creating more and more candidates for statin therapy. This wasn't based on new evidence showing people lived longer or became healthier - it was driven by pharmaceutical marketing disguised as healthcare policy.

The Power of Pharmaceutical Lobbying

The influence of pharmaceutical companies on healthcare policy cannot be overstated. Consider this: there are 535 voting members of Congress, but 1,820 full-time pharmaceutical industry lobbyists in Washington D.C. That's 3.4 lobbyists for every voting member of Congress.

Even more concerning, a 2004 study published in the Journal of the American Medical Association revealed that 8 out of 9 members of the NCEP panel had financial ties to statin manufacturers. By lowering cholesterol thresholds, they stood to profit directly from expanded statin use.

Cholesterol Levels and Heart Disease Risk

Despite decades of focus on cholesterol, the link between cholesterol levels and heart disease risk is far from clear-cut:

• Over 50% of heart attacks occur in people with "normal" cholesterol levels under 200 mg/dL
• A large Korean study found the lowest mortality rate in men over 65 was among those with cholesterol between 250-270 mg/dL - levels that would guarantee a statin prescription in many countries
• A Japanese study showed people with cholesterol between 220-260 mg/dL lived longer than those with levels under 200 mg/dL

These findings suggest that cholesterol itself isn't the problem. People with "normal" cholesterol still suffer heart attacks because the true root causes - insulin resistance, chronic low-grade inflammation, and oxidative stress - remain unaddressed.

Better Markers for Cardiovascular Risk

If total cholesterol and LDL aren't reliable indicators of heart disease risk, what should we be measuring? Here are some more informative markers:

LDL Particle Size and Number

Not all LDL is created equal. Small, dense LDL particles are more likely to penetrate artery walls and contribute to plaque formation. Large, fluffy LDL particles are generally benign. A test measuring LDL particle size and number provides more insight than a simple LDL cholesterol level.

Optimal results:

• Total LDL particle number under 1000 nmol/L
• Less than 20% of LDL particles should be small (under 20.5 nm in size)

Total Cholesterol to HDL Ratio

This ratio can be more informative than looking at total cholesterol alone:

• Ratio under 4.0 is generally good
• Ratio under 3.0 is excellent

For example:

• Total cholesterol 210 mg/dL, HDL 70 mg/dL = ratio of 3.0 (very good)
• Total cholesterol 240 mg/dL, HDL 60 mg/dL = ratio of 4.0 (still acceptable)
• Total cholesterol 180 mg/dL, HDL 30 mg/dL = ratio of 6.0 (concerning)

Triglyceride to HDL Ratio

This ratio is an excellent indicator of insulin resistance and metabolic health:

• Ratio under 2.0 is low risk
• Ratio over 3.5 is high risk

For those following a low-carbohydrate diet and with good insulin sensitivity, triglycerides often fall between 50-80 mg/dL, and HDL between 50-70 mg/dL, resulting in a ratio close to 1.0.

High-Sensitivity C-Reactive Protein (hs-CRP)

This marker measures inflammation in the body. Optimal levels are under 1.0 mg/L, though standard lab ranges often don't flag results until they exceed 3.0 mg/L.

Fasting Insulin

Fasting insulin is an excellent early indicator of insulin resistance. Optimal levels are between 2-5 μIU/mL. Unfortunately, many healthcare providers don't routinely test this, and standard ranges often don't flag results until they exceed 25 μIU/mL - by which point a person is essentially type 2 diabetic.

Hemoglobin A1C

This test measures long-term blood sugar control. The optimal range is between 4.8-5.3%. Standard ranges often don't flag results until they reach 5.7% (pre-diabetes) or 6.5% (diabetes).

Homocysteine

Homocysteine is a byproduct of liver metabolism and can be highly inflammatory when elevated. Optimal levels are under 7 μmol/L, though standard ranges often don't flag results until they exceed 15 μmol/L.

Addressing the Root Causes

Rather than focusing solely on cholesterol levels, we need to address the underlying factors that contribute to heart disease risk:

1. Insulin resistance
2. Chronic inflammation
3. Oxidative stress

These issues stem from unnatural lifestyles that don't respect our bodies' innate wisdom. We've introduced excessive sugar, alcohol, seed oils, chemicals, heavy metals, and electromagnetic fields into our environment. We suffer from lack of movement, poor sleep, and limited exposure to fresh air and sunlight.

By understanding the true risk factors and adopting a more natural lifestyle, most people can optimize their health markers without relying on medication. This approach treats the root causes rather than masking symptoms.

Conclusion

The cholesterol myth has led millions of people to take statins unnecessarily, potentially causing more harm than good. By understanding the true nature of cholesterol and focusing on more relevant health markers, we can make better decisions about our cardiovascular health.

Remember, cholesterol isn't the enemy - it's an essential substance our bodies need to function properly. Instead of vilifying cholesterol, we should focus on addressing the root causes of heart disease through lifestyle changes and more comprehensive testing.

By respecting our bodies' natural processes and adopting healthier habits, we can achieve optimal health without relying on medications that may do more harm than good in the long run.

Article created from: https://youtu.be/dQLkDijNE2A?feature=shared